Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2008
10/23/2008WO2008126430A1 Method for evaluation of tissue preservation solution
10/23/2008WO2008126413A1 Tem8 peptides and vaccines comprising the same
10/23/2008WO2008126083A2 Methods for identification and selection of human embryonic stem cell derived cells
10/23/2008WO2008126065A2 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/23/2008WO2008126039A2 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods
10/23/2008WO2008125983A2 Methods of increasing plant growth
10/23/2008WO2008125972A2 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
10/23/2008WO2008125816A1 Modulation of cellular proliferation
10/23/2008WO2008125720A1 Expression vectors which include the human pklr gene promoter and use thereof for preparing pharmaceutical compositions for somatic genetic therapy with specific expression in erythroid cells
10/23/2008WO2008125528A2 Polynucleotides for regulation of high level tissue-preferred expression in crop plants
10/23/2008WO2008125433A1 Plant tissue with an altered content of a flavonoid component
10/23/2008WO2008125362A1 Controlling pests by combining insecticides and transgenic plants by applying directly to leaves and roots
10/23/2008WO2008125280A2 New modulating molecules for an improved regulated expression system
10/23/2008WO2008125245A1 Method for better utilising the production potential of transgenic plants
10/23/2008WO2008125222A2 New modulation molecules for an improved regulated expression system
10/23/2008WO2008125119A1 Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a
10/23/2008WO2008125117A1 Cell culture system of a hepatitis c genotype 3a and 2a chimera
10/23/2008WO2008125116A2 Upar inhibition
10/23/2008WO2008124934A1 Constructs for enhancement of gene expression in muscle
10/23/2008WO2008124933A1 Carbon and nitrogen-regulating gene and protein and modulation thereof
10/23/2008WO2008124927A1 Sirna against thymidylate synthase and uses thereof in cancer treatment regimens
10/23/2008WO2008124858A2 Targeted receptor
10/23/2008WO2008109369A8 Nucleic acid compounds for inhibiting tnf gene expression and uses thereof
10/23/2008WO2008097926A3 Transient transfection with rna
10/23/2008WO2008097267A3 Vaccines against vesicular stomatitis
10/23/2008WO2008096070A3 Cell line having a high transcription activity for the production of proteins, in particular therapeutic proteins
10/23/2008WO2008086386A3 Adenoviral vector-based malaria vaccines
10/23/2008WO2008086035A3 Split mutant hydrolase fusion reporter and uses thereof
10/23/2008WO2008073877A3 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
10/23/2008WO2008070367A3 Mammalian cell-based immunoglobulin display libraries
10/23/2008WO2008067180A3 Centrosomal proteins and secretion
10/23/2008WO2008067089A3 Light-regulated transcription system for use in prokaryotic organisms
10/23/2008WO2008067019A3 Phospholipase c and method of use
10/23/2008WO2008063802A3 Suppression of mitochondrial oxidative stress
10/23/2008WO2008063577A3 Phospholipase c zeta mediated oocyte activation
10/23/2008WO2008060705A3 Anti-dll4 antibodies and methods using same
10/23/2008WO2008057470A3 Identification of bitter ligands that specifically activate human t2r receptors and related assays for identifying human bitter taste modulators
10/23/2008WO2008053330A3 Monoclonal antibodies against the human anti-mullerian hormone type ii receptor (amhr-ii)
10/23/2008WO2008052101A3 Multiplex automated genome engineering
10/23/2008WO2008036863A3 Phospholipases, nucleic acids encoding them and methods for making and using them
10/23/2008WO2008036841A3 Tripartite oligonucleotide complexes and methods for gene silencing by rna interference
10/23/2008WO2008023263A3 Flavin monooxygenases and transcription factors involved in glucosinolate biosynthesis
10/23/2008WO2007137156A3 Rnai modulation of aha and therapeutic uses thereof
10/23/2008WO2007127735A3 Prokaryotic host cells for expressing proteins rich in disulfide bonds
10/23/2008WO2007109254A3 Stabilized polypeptide compositions
10/23/2008WO2007066779A9 Novel lipase
10/23/2008WO2005121352A3 Carotenoid ketolase genes with improved ketocarotenoid yield
10/23/2008US20080263729 Stress Tolerant Organisms Expressing a Map Kinase Homologue
10/23/2008US20080263728 Plastidial targeting peptide
10/23/2008US20080263727 Increased seed size and seed number through transgenic over expression of revoluta protein during early embryo development
10/23/2008US20080263726 Short vegetative phase (SVP) gene protein for enhancing flowering time in crop plants
10/23/2008US20080263725 expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress (drought, cold, oxidation)
10/23/2008US20080263722 Expression vector comprising nucleotide sequences coding dehydration response element binding factors(DREB1 and DREB2) for use as tools in generating drought and salt resistant crops
10/23/2008US20080263719 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid synthesis and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263718 Soybean cultivar 6226454
10/23/2008US20080263712 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid synthesis and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263711 Plants and seeds of corn variety cv076785
10/23/2008US20080263710 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid synthesis and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263709 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid synthesis and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263708 Plants and seeds of corn variety cv795034
10/23/2008US20080263707 Plants and seeds of corn variety cv390455
10/23/2008US20080263706 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid synthesis and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263705 Plants and seeds of corn variety cv591539
10/23/2008US20080263704 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid synthesis and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263703 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid synthesis and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263702 Soybean cultivar 6547272
10/23/2008US20080263701 Soybean cultivar 6929431
10/23/2008US20080263700 Soybean cultivar 6703392
10/23/2008US20080263699 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid synthesis and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263698 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263697 Soybean cultivar 6719022
10/23/2008US20080263696 Soybean cultivar 5826056
10/23/2008US20080263695 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263694 Soybean cultivar 6719331
10/23/2008US20080263693 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263692 Using mixture comprising centrosome protein, mitotic motor protein and sperm centrosomal components to enhance efficacy of nuclear transfer into primates; tissue engineering; gene therapy
10/23/2008US20080263691 Expression vector comprising nuclelotide sequences coding troponin I (TnI) protein for use in treatment and prevention of congestive heart failure
10/23/2008US20080263688 Hafnia Phytase
10/23/2008US20080263687 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
10/23/2008US20080263685 Transgenic non-human animal expressing metabotropic glutamate receptor 1 in a melanocyte-specific manner for identifying modulators for prevention and treatment of cell proliferative disorders
10/23/2008US20080263683 Animal models expression receptors for advanced glycation end-products (RAGE) and inducible nitric oxide synthase for use as tool in identifying modulators for treatment and prevention of glomerular disorders
10/23/2008US20080262213 Bioreactor comprising solid support containing immobilized polylysine for use in propagation of polynucleotide sequences
10/23/2008US20080262212 Using 40-60 mers of DNA that overlap with staggered complementary oligomers to propagate and design preferential gene sequences; directed protein evolution
10/23/2008US20080262211 Hepatitis-c virus type 4, 5 and 6
10/23/2008US20080262204 A purified affinity-matured antibody or a portion thereof having binding specificity for 83 kDa protective antigen (PA83) of Bacillus anthracis; confers protection to a host against a tripartite toxin of Bacillus anthracis; cloned from an anti-Bacillus anthracis PA83 hybridoma
10/23/2008US20080262202 Novel cancer-associated genes
10/23/2008US20080262201 Method and a system for predicting protein functional site, a method for improving protein function, and a function-modified protein
10/23/2008US20080261912 For treatment of endocrine-regulated tumors, for example, breast, prostate, ovarian and colon cancers
10/23/2008US20080261907 siRNA blocks expression of sphingosine kinase, potentiates effect of radiation in cancer cells of breast, prostate, colorectal, lung, bladder, head and neck, intestine, ovarian, skin; reduces amount of radiation needed to decrease cancer cell viability, tumor size in vivo
10/23/2008US20080261905 Hexoses selected from tetrahydropyran; Preferred are hexitol, altritol, substituted altritols; novel modified nucleosides and nucleotides in single or double stranded oligonucleotides for RNA interference, antisense therapy; inhibit or decrease the expression of P-glycoprotein efflux pumps; cancer
10/23/2008US20080261904 Synthesized oligomers complementary to and capable of hybridizing to a selected target nucleic acid; internucleoside linking; three regions differentiated by differentially modified ribofuranosyl sugar moieties; antisense and sense oligomeric compound; inhibiting gene expression
10/23/2008US20080261903 Isolated polynucleotide encoding a Regulated in chronic obstructive pulmonary disease Kinase polypeptide; host cell; hybridization; screening; prediction, diagnosis; prognosis; chronic obstructive pulmonary disease, asthma, cancer, diseases of defective cell signaling
10/23/2008US20080261883 Runx3 gene showing anti-tumor activity and use thereof
10/23/2008US20080261882 Methods for Inhibiting Heregulin and Treating Cancer
10/23/2008US20080261879 Activin (follistatin) receptors; inhibin; neuronal differentiation; transforming growth factors
10/23/2008US20080261878 In-vivo assay; tau protein; amyloid precursor proteins; neurodegenerative diseases
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261867 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/23/2008US20080261863 Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use
10/23/2008US20080261862 Integrin mediates proliferative signal provided by CD23 to pre-B cells; immobilized rodent cells; drug screening; anticancer agents; antiinflammatory agents